Tufts Center for the Study of Drug Development

We recently had the privilege of collaborating with a local pharmaceutical company to deliver an in-depth, live professional development course on the complexities of drug development. Over the course of three months, 28 colleagues gathered bi-weekly to explore everything from bench to bedside, led by Tufts CSDD Senior Fellow Robert Franco, PhD, and Operations & Development Manager Sarah Wrobel, MHA. This immersive program empowered participants with the skills and knowledge to navigate the dynamic & fast-paced biopharmaceutical landscape.    Interested in learning more about our tailored professional development programs? Reach out to Sarah Wrobel, MHA, at [email protected]   #DrugDevelopment  #PharmaExcellence  #ProfessionalGrowth    Yun Wang | Harper Lee Kaye | Varun Garg | Lindsay McNair, MD, MPH, MSB | Jerald S. Schindler, Zeid Barakat | Christine Carberry | Chris Albani

Where do you fall along the maturity curve of DCT solutions? Are you: * Beginning to explore decentralized clinical trial (DCT) approaches? * Implementing DCT components with a structured strategy? * Advancing to a maturity level where decentralized approaches are comprehensively embraced? * Leading the way and pioneering DCT practices while setting industry standards? The PACT Consortium offers an opportunity to collaborate with diverse stakeholders across all maturity levels to revolutionize clinical trials. Join the PACT Consortium today to share your insights and help drive innovation. Visit https://lnkd.in/ehsWfC-h today or connect with Joan Chambers.

Pharmaceutical R&D is becoming more complex, but the opportunities for transformation are growing too. The Tufts CSDD Circle of Supporters brings thought leaders together to tackle R&D’s toughest challenges and advance our mission to deliver trusted, data-driven insights worldwide. Discover the benefits of membership. Visit https://lnkd.in/ecU4iKrP or connect with Joan Chambers.

Insights identify opportunities to optimize sponsor, CRO, and site collaborations🖊️Beth Harper, Project Manager, Senior Research Consultant;Zachary Smith, Assistant Director, Data Sciences and Analytics; Ruby Ford, MPH Ruby Madison Ford, Research Analyst; and Ken Getz, Executive Director and Professor; all with Tufts Center for the Study of Drug Development

Measuring Impact of DCT Methods: A New Era in Clinical Trials Diving into how decentralized clinical trials (DCT) are revolutionizing patient enrollment and increasing access for diverse communities. With strategic tactics, key KPIs, and real-time data, the impact is clear. Access the panel discussion recording from the DTRA Annual 2024 Meeting in November moderated by Brandon Maggio of GSK, with industry experts Zachary Smith (Tufts CSDD), Christoph Hornik (Duke Clinical Research Institute), and Dr. Timil Patel (FDA). 🔗 https://lnkd.in/eQUR4fzJ #DCT #ClinicalTrials #HealthcareInnovation 

Are you looking for original research, analysis, and insight into critical drug development issues and the clinical trials landscape? The Tufts CSDD bi-monthly publication provides all this cutting-edge information to help you stay informed about ongoing industry trends. Start your annual subscription today. Multi-reader programs are also available. Visit https://lnkd.in/dSYX898E or contact Joan Chambers at [email protected] 

DCT solutions offer opportunities to reduce participant burden, improve patient access, increase participation from underrepresented groups, and enhance convenience for patients, caregivers, and families. PACT Consortium member organizations collaborate to gather robust evidence on the use of DCTs, examine specific elements in greater depth, and explore much more. Join this digital transformation by becoming a member of the PACT Consortium. Visit https://lnkd.in/ehsWfC-h today or connect with Joan Chambers. #DCT #ClinicalTrials #Patients #DigitalHealth #Diversity

From groundbreaking studies on AI in drug development to in-depth analyses of clinical trial efficiency, it’s been a month of dynamic research and vibrant discussions. We're proud to see our work sparking conversations across LinkedIn, the media, and the industry. Stay connected with us as we continue exploring patient participation, risk-based monitoring, and strategies to enhance clinical trial outcomes. 💡 Ready to collaborate or learn more? Visit our website or reach out directly. Let’s shape the future of drug development together: https://csdd.tufts.edu/ #TuftsCSDD #ClinicalResearch #DrugDevelopment #Innovation

The complexities of pharmaceutical R&D are increasing, but so are opportunities for transformation. The Tufts CSDD Circle of Supporters brings together thought leaders to tackle R&D’s toughest challenges and supports our mission to deliver trusted, data-driven insights to stakeholders worldwide. Learn more about becoming a Circle of Supporters member and its benefits. Visit https://lnkd.in/ecU4iKrP or connect with Joan Chambers.

Today, several innovative #clinical_trial execution models are emerging, including site staff embedded within #clinical_care settings, remote sites, mobile sites, and #home_health_services. Simultaneously, #Site_Management_Organizations and #Site_Networks have scaled and continue to expand. This session at the #SCOPESummit will offer valuable insights into the evolving global site landscape. We look forward to seeing you at SCOPE in Orlando!